Results 111 to 120 of about 214,804 (267)

Analysis of Positive Patch Test Allergens in Allergic Contact Dermatitis Patients with Atopic Dermatitis. [PDF]

Ann Dermatol, 2023
Choi YJ, Byun JY, Choi YW, Roh JY, Choi HY.   +4 more
europepmc   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

Molecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq, Marc Terrones, Felicia Rodrigues Fortes, Anne Schepers, Alessia Denis, Christophe Deben, Ken Op de Beeck, Guy Van Camp, Geert Vandeweyer   +8 more
wiley   +1 more source

The benefit of late patch test readings in corticosteroid allergy. [PDF]

Contact Dermatitis, 2022
Svendsen SV, Mortz CG.
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

A multicenter study by the Brazilian Society of Dermatology on a new standard patch test series. [PDF]

An Bras Dermatol
Bonamigo RR, Rocha VB, Reis VMSD, Rodrigues DF, Lazzarini R, Pires MC, Hikawa RS, Kiszewski AE, França AFEDC, Heck R, Scherrer MAR, Samorano LP, Cordeiro ICM, Duarte IA, Hafner MFS, Pires RMG, Eller LS, Rodrigues JB, Bumaguin DB, Hahnstadt RL.   +19 more
europepmc   +1 more source

Usefulness of dermoscopy in the evaluation of patch test reactions. [PDF]

An Bras Dermatol, 2021
Oppermann K, Cattani CAS, Bonamigo RR.
europepmc   +1 more source

Atopy patch test

Indian Journal of Dermatology, Venereology and Leprology, 2019
Varsha, Vaidyanathan, Aarti, Sarda, Abhishek, De, Sandipan, Dhar   +3 more
openaire   +2 more sources

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Metal Sensitization in Patients That Underwent Patch Test Pre and Post-Implant Exposure. [PDF]

Contact Dermatitis
Zampa N, Lazzarato I, Mauro M, Tassinari A, Cegolon L, Larese Filon F.   +5 more
europepmc   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source